Products 88901-39-7

CAS 88901-39-7 appears in our catalog under these names: Mogroside I E1/ 99.71% (existing batch purity), Mogroside I E1, Mogroside I E1, 98%, 98%, Mogroside I E1, 98.46%. Offered by: TargetMol, Biosynth, Chemat, MedChemExpress. Available pack sizes: 1mg, 5mg, 10mg, 25mg, 50mg, 5 mg, 50 mg, 25 mg.

Mogroside I E1/ 99.71% (existing batch purity)
TargetMol
  • size: 1mg, 5mg, 10mg, 25mg
  • Variants: 5
from 1003.28
View product
Mogroside I E1
Biosynth
  • size: 25mg, 10mg, 50mg
  • Variants: 3
View product
Mogroside I E1, 98%, 98%
Chemat
  • size: 5mg, 10mg, 25mg
  • Variants: 3
from 698.00
View product
Mogroside I E1, 98.46%
MedChemExpress
  • size: 5 mg, 50 mg, 25 mg, 10 mg
  • Variants: 5
from 1007.00
View product
Structural formula: {0} (CAS {1})

Mogroside IE is a mogroside that is mogrol in which the hydroxyl hydrogen at position 3 has been replaced by a beta-D-glucosyl residue. It has a role as a plant metabolite. It is a mogroside, a beta-D-glucoside and a monosaccharide derivative. It is functionally related to a mogrol.

Source: ChEBI

Identity
Molecular formulaC36H62O9
Molecular weight638.9 g/mol
IUPAC name(2R,3R,4S,5S,6R)-2-[[(3S,8S,9R,10R,11R,13R,14S,17R)-17-[(2R,5R)-5,6-dihydroxy-6-methylheptan-2-yl]-11-hydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol
InChIKeyLLZGAVAIPZROOJ-FDWAMWGASA-N
SMILESC[C@H](CC[C@H](C(C)(C)O)O)[C@H]1CC[C@@]2([C@@]1(C[C@H]([C@@]3([C@H]2CC=C4[C@H]3CC[C@@H](C4(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)C)O)C)C

Computed by PubChem (NCBI)

Synonyms: mogroside IE, Mogroside I E1, Mogroside IE1, Mogroside I-E1, 3-O-beta-D-glucosylmogrol, mogrol 3-O-beta-D-glucoside, orb1309401, (24R)-cucurbit-5-ene-3beta,11alpha,24,25-tetrol 3-beta-D-glucoside
Isomers (same molecular formula)
(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol C36H62O9
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol C36H62O9
(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2R)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol C36H62O9
(2S,3R,4S,5S,6R)-2-[(3R,6R)-6-[(3S,8S,9R,10R,11R,13R,14S,17R)-3,11-dihydroxy-4,4,9,13,14-pentamethyl-2,3,7,8,10,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-hydroxy-2-methylheptan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol C36H62O9